首页> 美国卫生研究院文献>Journal of Atherosclerosis and Thrombosis >Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

【2h】

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

机译：经皮冠状动脉介入稳定冠状动脉疾病患者TicagreloLor和Clopidogrel的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim:The efficacy and safety of ticagrelor and clopidogrel in patients with stable coronary artery disease (SCAD) undergoing percutaneous coronary intervention (PCI) remain uncertain. Thus, this study aimed to compare the efficacy and safety of ticagrelor and clopidogrel in patients with SCAD treated with PCI.

机译：目的：TicagreloLoLoLoL和Clopidogrel在经皮冠状动脉疾病（PCI）稳定冠状动脉疾病（SCA）患者中的疗效和安全性仍然不确定。因此，本研究旨在比较用PCI处理苏达患者TicagreloLoR和Clopidogrel的疗效和安全性。

著录项

期刊名称 Journal of Atherosclerosis and Thrombosis
作者
Jianan Li; Hong Qiu; Lirong Yan; Tingting Guo; Yong Wang; Yang Li; Jianfeng Zheng; Yida Tang; Bo Xu; Shubin Qiao; Yuejin Yang; Runlin Gao;
展开▼
作者单位

展开▼
年(卷),期 2021(28),8
年度 2021
页码 873–882
总页数 10
原文格式 PDF
正文语种
中图分类心脏疾病;
关键词

机译：Ticagrelor;氯吡格雷;稳定的冠状动脉疾病;经皮冠状动脉介入;

相似文献

外文文献
中文文献
专利

1. Letter by Long et al Regarding Article, “Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease” [J] . Manyun Long, Ziliang Ye, Lang Li Circulation: An Official Journal of the American Heart Association . 2019,第11期

机译：Long等人关于文章的信，“TicagreloR的两剂方案与氯吡格雷对稳定冠状动脉疾病进行经皮冠状动脉疾病的患者相比”
2. Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease [J] . Orme Rachel C., Parker William A. E., Thomas Mark R., Circulation: An Official Journal of the American Heart Association . 2018,第13期

机译：与氯吡格雷对稳定冠状动脉疾病进行经皮冠状动脉介入的患者氯吡格雷相比的两剂量方案研究
3. Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention [J] . He-Yang Wang, Yi Li, Xiao-Ming Xu, 中华医学杂志（英文版） . 2018,第017期

机译：基线出血风险对经皮冠状动脉介入治疗的中国急性冠脉综合征患者替卡格雷和氯吡格雷疗效和安全性的影响
4. Evaluation of Oxidized Low-Density Lipoprotein in the Coronary Circulation of Patients with Coronary Artery Disease, and its Association with Percutaneous Coronary Intervention [C] . M.M. Ramadan, M. Kodama, S. Hirono, International Congress on Coronary Artery Disease . 2007

机译：冠状动脉疾病患者冠状动脉循环中氧化低密度脂蛋白的评价及其与经皮冠状动脉介入的关联
5. A comparison of selected preoperative coronary artery disease risk factors in patients 40 years or younger and patients over 40 years undergoing coronary artery bypass graft surgery. [D] . Frye, Laurie Perry. 2002

机译：比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
6. Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease [O] . Rachel C. Orme, William A.E. Parker, Mark R. Thomas, -1

机译：替卡格雷与氯吡格雷两种剂量方案在经皮冠状动脉介入治疗稳定型冠心病患者中的比较研究
7. THE EFFICACY AND SAFETY OF TICAGRELOR AS COMPARED TO CLOPIDOGREL, WITH AND WITHOUT A GLYCOPROTEIN IIB/IIIA INHIBITOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS INTERVENTION: A PLATO (STUDY OF PLATELET INHIBITION AND PATIENT OUTCOMES) ANALYSIS [O] . Bansilal Sameer, Wiviott Stephen, Becker Richard, 2013

机译：接受过定期介入治疗的急性冠状动脉综合征患者中，替加格雷的疗效和安全性与氯吡格雷相比，有或没有糖蛋白IIB / IIIA抑制剂的疗效和安全性：普拉托（血小板抑制和分析）

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

摘要

著录项

相似文献

相关主题

期刊订阅